HSGX stock forecast
Our latest prediction for Histogenics Corp.'s stock price was made on the Oct. 10, 2018 when the stock price was at 0.52$.
In the short term (2weeks), HSGX's stock price should outperform the market by 6.60%. During that period the price should oscillate between -7.83% and +24.07%.
In the medium term (3months), HSGX's stock price should outperform the market by 11.70%. During that period the price should oscillate between -17.20% and +54.54%.Get email alerts
About Histogenics Corp.
Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.93$ per share.
The book value per share is -0.81$
Three months stock forecastOct. 10, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|